Pharmaxis Ltd (AU:SNT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pharmaxis Ltd has announced a significant increase in the options held by Director Gary Jonathan Phillips, under the Syntara Employee Option Plan. Following shareholder approval, Phillips’ direct options have risen from 6,845,800 to 9,616,800, reflecting a strategic move within the company. This development may intrigue investors tracking executive actions within Pharmaxis Ltd.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
